Tumor angiogenesis: Role in locally aggressive biological behavior of ameloblastoma and keratocystic odontogenic tumor

Head and Neck

Volumn 35, Issue 3, 2013, Pages 329-334

  Gadbail, Amol Ramchandra ^a   Mankar, Mugdha P ^a   Hande, Alka ^a   Chaudhary, Minal S ^a   Gondivkar, Shailesh M ^b   Korde, Sheetal ^c   Gawande, Madhuri N ^a   Patil, Swati ^a   Tekade, Satyjitraje ^d   Sharma, Aparna ^e  

^a DATTA MEGHE INSTITUTE OF MEDICAL SCIENCES   (India)

^b MGV's KBH Dental College And Hospital   (India)

^c YMT Dental College   (India)

^d Modern Dental College and Research Center   (India)

^e Research Centre   (India)

Author keywords

ameloblastoma; CD105 (endoglin); dentigerous cyst; keratocystic odontogenic tumor; tumor angiogenesis

Indexed keywords

ENDOGLIN;

AMELOBLASTOMA; ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MOUTH MUCOSA; ODONTOGENIC KERATOCYST; PRIORITY JOURNAL; TERATOMA; TUMOR ANGIOGENESIS;

EID: 84874035613     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.22960     Document Type: Article

References (59)

1. Junquera L, Ascani G, Vicente JC, Garcia-Consuegra L, Roig P,. Ameloblastoma revisited. Ann Otol Rhinol Laryngol. 2003; 112: 1034-1039.
2. Reichart PA, Philipsen HP,. Odontogenic tumors and allied lesions. London: Quintessence; 2004. pp 43-48.
3. Gardner DG, Heikinheimo K, Shear M, Philipsen HP, Coleman H,. Ameloblastomas. In:, Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization Classification of Tumors, Pathology and Genetics Head and Neck Tumors. Lyon: IARC Press; 2005. pp 296-300.
4. Kumamoto H,. Molecular pathology of odontogenic tumors. J Oral Pathol Med. 2006; 35: 65-74.
5. Chirapathomsakul D, Sastravaha P, Jansisyanont P,. A review of odontogenic keratocysts and the behavior of recurrences. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 5-9; discussion 10.
6. Shear M,. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 1. Clinical and early experimental evidence of aggressive behaviour. Oral Oncol 2002; 38; 219-226.
7. Shear M,. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 2. Proliferation and genetic studies. Oral Oncol 2002: 38; 323-331.
8. Gadbail AR, Chaudhary M, Patil S, Gawande M,. Actual Proliferating Index and p53 protein expression as prognostic marker in odontogenic cysts. Oral Dis. 2009; 15: 490-498.
9. Barnes L, Eveson JW, Reichart P, Sidransky D,. World Health Organization Classification of Tumors. WHO Histological classification of odontogenic tumors. Lyon: IARC Press; 2005. pp 306-307.
10. Shear M,. Odontogenic keratocyst and dentigerous cyst in cysts of the oral regions, 3rd ed. Oxford: Butterworth-Heinemann; 1992.
11. de Oliveira MD, de Miranda JL, de Amorim RF, de Souza LB, de Almeida Freitas R,. Tenascin and fibronectin expression in odontogenic cysts. J Oral Pathol Med. 2004; 33: 354-359.
12. Galiè M, Sorrentino C, Montani M, et al. Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells. Carcinogenesis. 2005; 26: 1868-1878.
13. De Wever O, Mareel M,. Role of myofibroblasts at the invasion front. Biol Chem. 2002; 383: 55-67.
14. De Wever O, Mareel M,. Role of tissue stroma in cancer cell invasion. J Pathol. 2003; 200: 429-447.
15. Carmeliet P, Jain RK,. Angiogenesis in cancer and other diseases. Nature. 2000; 407: 249-257.
16. Folkman J,. Angiogenesis in cancer, vascular, rheumatoid, and other disease. Nat Med. 1995; 1: 27-31.
17. Hillen F, Griffioen AW,. Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev. 2007; 26: 489-502.
18. Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M,. Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene. 2003; 22: 6557-6563.
19. Sanchez-Elsner T, Botella LM, Velasco B, Langa C, Bernabeu C,. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J Biol Chem. 2002; 277: 43799-43808.
20. Minhajat R, Mori D, Yamasaki F, Sugita Y, Satoh T, Tokunaga O,. Organ-specific endoglin (CD105) expression in the angiogenesis of human cancers. Pathol Int. 2006; 56: 717-723.
21. Ding S, Li C, Lin S, et al. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions. Hum Pathol. 2006; 37: 861-866.
22. Weidner N, Semple JP, Welch WR, Folkman J,. Tumor angiogenesis and metastasis: correlation in invasion breast carcinoma. N Engl J Med. 1991; 324: 1-8.
23. Marioni G, Alessandro ED, Giacomelli L, Staffieri A,. CD105 is a marker of tumour vasculature and a potential target for the treatment of head and neck squamous cell carcinoma. J Oral Pathol Med. 2010; 39: 361-367.
24. Legan M,. New marker of angiogenesis CD105 (endoglin): diagnostic, prognostic and therapeutic role. Radiol Oncol. 2005; 39: 253-259.
25. Fonsatti E, Maio M,. Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer. J Transl Med 2004; 2: 18.
26. Tanaka F, Otake Y, Yanagihara K, et al. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Clin Cancer Res. 2001; 7: 3410-3415.
27. Saad RS, Liu YL, Nathan G, Celebrezze J, Medich D, Silverman JF,. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Mod Pathol. 2004; 17: 197-203.
28. Martone T, Rosso P, Albera R, et al. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome. Oral Oncol. 2005; 41: 147-155.
29. Ho JW, Poon RT, Sun CK, Xue WC, Fan ST,. Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver. World J Gastroenterol. 2005; 11: 176-181.
30. Piatelli A, Fioroni M, Santinelli A, Rubini C,. Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts. Oral Oncol. 1998; 34: 408-412.
31. Li TJ, Brown RM, Mathews JB,. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in unicystic ameloblastoma. Histopathology. 1995; 26: 219-228.
32. Piatelli A, Lezzi G, Fioroni M, Santinelli A, Rubini C,. Ki-67 expression in dentigerous cysts, unicystic ameloblastoma, and ameloblastomas arising from dental cysts. J Endod. 2002; 28: 55-58.
33. Hande AH, Gadbail AR, Sonone AM, Chaudhary MS, Wadhwan V, Nikam A,. Comparative analysis of tumour angiogenesis in solid multicystic and unicystic ameloblastoma by using CD 105 (endoglin). Arch Oral Biol. 2011; 56: 1635-1640.
34. Chen WL, Ouyang KX, Li HG, Huang ZQ, Li JS, Wang JG,. Expression inducible nitric oxide synthetase and vascular endothelial growth factor in ameloblastoma. J Craniofac Surg. 2009; 20: 171-175.
35. Alaeddini M, Salah S, Dehghan F, Eshghyar N, Etemad-Moghadam S,. Comparison of angiogenesis in keratocyst odontogenic tumours, dentigerous cysts and ameloblastomas. Oral Dis. 2009; 15: 422-427.
36. Seifi S, Shafaie S, Ghadiri S,. Microvessel density in follicular cysts, keratocystic odontogenic tumours and ameloblastomas. Asian Pacific J Cancer Prev. 2011; 12: 351-356.
37. Migaldi M, Sartori G, Rossi G, Cittadini A, Sgambato A,. Tumor cell proliferation and microsatellite alterations in human ameloblastoma. Oral Oncol. 2008; 44: 50-60.
38. Kumamoto H, Ohki K, Ooya K,. Association between vascular endothelial growth factor (VEGF) expression and tumour angiogenesis in ameloblastomas. J Oral Pathol Med. 2002; 31: 28-34.
39. Mitrou GK, Tosios KI, Kyroudi A, Sklavounou A,. Odontogenic keratocyst expresses vascular endothelial growth factor: an immunohistochemical study. J Oral Pathol Med. 2009; 38: 470-475.
40. Kumar V, Abbas AK,., Fausto N,. Robbins and Cotran Pathologic Basis of Diseases. 7th ed. Philadelphia: Saunders; 2004. pp 309-311.
41. Ribeiro BF, Iglesias DP, Nascimento GJ, Galvão HC, Medeiros AM, Freitas RA,. Immunoexpression of MMPs-1, -2, and -9 in ameloblastoma and odontogenic adenomatoid tumor. Oral Dis. 2009; 15: 472-477.
42. Pinheiro JJ, Freitas VM, Moretti AI, Jorge AG, Jaeger RG,. Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity. Histopathology. 2004; 45: 65-72.
43. Shen LC, Chen YK, Hsue SS, Shaw SY,. Expression of osteonectin/secreted protein acidic and rich in cysteine and matrix metalloproteinases in ameloblastoma. J Oral Pathol Med. 2010; 39: 242-249.
44. Zhang B, Zhang J, Huang HZ, Xu ZY, Xie HL,. Expression and role of metalloproteinase-2 and endogenous tissue regulator in ameloblastoma. J Oral Pathol Med. 2010; 39: 219-222.
45. Iezzi G, Piattelli A, Rubini C, et al. Expression of transforming growth factor beta1 in ameloblastomas. J Craniofac Surg. 2008; 19: 1618-1621.
46. Khalifa GA, Shokier HM, Abo-Hager EA,. Evaluation of neoplastic nature of keratocystic odontogenic tumor versus ameloblastoma. J Egypt Natl Canc Inst. 2010; 22: 61-72.
47. Amorim RF, Godoy GP, Galvao HC, Souza LB, Freitas RA,. Immunohistochemical assessment of extracellular matrix components in syndrome and non-syndrome odontogenic keratocysts. Oral Dis. 2004; 10: 265-270.
48. da Silva TA, Batista AC, Mendonça, EF, Leles CR, Fukada S, Cunha FQ,. Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 105: 333-341.
49. Poomsawat S, Punyasingh J, Weerapradist W,. Expression of basement membrane components in odontogenic cysts. Oral Dis. 2006; 12: 290-296.
50. Hirshberg A, Sherman S, Buchner A, Dayan D,. Collagen fibers in the wall of odontogenic keratocysts: a study with picrosirius red and polarizing microscopy. J Oral Pathol Med. 1999; 28: 410-412.
51. El-Labban NG, Aghabeigi B,. A comparative stereologic and ultrastructural study of blood vessels in odontogenic keratocysts and dentigerous cysts. J Oral Pathol Med. 1990; 19: 442-446.
52. Gadbail AR, Hande A, Chaudhary M, et al. Tumor angiogenesis in keratocystic odontogenic tumor assessed by using CD-105 antigen. J Oral Pathol Med. 2011; 40: 263-269.
53. Wang Y, Liu B,. High expression of osteopontin and CD44v6 in odontogenic keratocysts. J Formos Med Assoc. 2009; 108: 286-292.
54. Masloub SM, Abdel-Azim AM, Elhamid ES,. CD10 and osteopontin expression in dentigerous cyst and ameloblastoma. Diagn Pathol 2011; 6: 44.
55. Bayless KJ, Salazar R, Davis GE,. RGD-dependent vacuolation and lumen formation observed during endothelial cell morphogenesis in three-dimensional fibrin matrices involves the alpha(v)beta(3) and alpha(5)beta(1) integrins. Am J Pathol. 2000; 156: 1673-1683.
56. González-Alva P, Kikuchi K, Miyazaki Y, et al. Expression of heparanase: a possible role in invasiveness and aggressive clinical behavior of ameloblastomas. J Oral Sci. 2010; 52: 39-47.
57. Katase N, Nagatsuka H, Tsujigiwa H, et al. Analysis of the neoplastic nature and biological potential of sporadic and nevoid basal cell carcinoma syndrome associated keratocystic odontogenic tumor. J Oral Pathol Med. 2007; 36: 550-554.
58. Vlodavsky I, Abboud-Jarrous G, Elkin M, et al. The impact of heparanese and heparin on cancer metastasis and angiogenesis. Pathophysiol Haemost Thromb. 2006; 35: 116-127.
59. Vered M, Shohat I, Buchner A, Dayan D,. Myofibroblasts in stroma of odontogenic cysts ant tumors can contribute to variations in the biological behaviour of lesions. Oral Oncol. 2005; 41: 1028-1033.